Literature DB >> 2841234

Altered function of DNA topoisomerases as a basis for antineoplastic drug action.

W E Ross, D M Sullivan, K C Chow.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2841234

Source DB:  PubMed          Journal:  Important Adv Oncol        ISSN： 0883-5896


× No keyword cloud information.
  5 in total

Review 1.  Topoisomerases, new targets in cancer chemotherapy.

Authors:  J G Zijlstra; S de Jong; E G de Vries; N H Mulder
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

2.  Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene.

Authors:  T Asano; T An; J Mayes; L A Zwelling; E S Kleinerman
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

3.  Can nuclear medicine predict response to chemotherapy?

Authors:  J L Moretti; M Caglar; M Duran-Cordobes; J F Morere
Journal:  Eur J Nucl Med       Date:  1995-02

4.  Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.

Authors:  S de Jong; J G Zijlstra; N H Mulder; E G de Vries
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 5.  Topoisomerase expression in cancer cell lines and clinical samples.

Authors:  L A Doyle
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.